• Interim Division Chief, Pediatric Emergency Medicine, UH Rainbow Babies and Children's Hospital
  • Assistant Professor, Pediatrics, CWRU School of Medicine

Request an Appointment

Refer a Patient

(216)844-8716

  • Gender: Male

Bio

Haitham Haddad, MD, FAAP, is Interim Division Chief and Medical Director of the Division of Pediatric Emergency Medicine and Attending Physician, Pediatric Sedation Unit at University Hospitals Rainbow Babies & Children’s Hospital. He is Assistant Professor, Pediatrics, Case Western Reserve University School of Medicine.

Dr. Haddad is board certified in pediatrics and certified in pediatric advanced trauma life support and pediatric advanced life support. His special interest is in pediatric emergency care and viral bronchial infections.

Dr. Haddad is a graduate of Damascus University Medical School, Damascus, Syria. He completed his residency in pediatrics at MetroHealth Medical Center, Cleveland, Ohio, and a fellowship in neonatology and pediatric intensive care at MetroHealth Medical Center and UH Rainbow Babies & Children’s Hospital.

Dr. Haddad joined the UH Rainbow Babies & Children’s Hospital staff in 2000 from Mt. Sinai East Medical Center, Cleveland, Ohio, where he was Director of Pediatric Medicine.

He is a Fellow of the American Academy of Pediatrics and a member of the American College of Ethical Physicians.

Honors and Recognition

Fellow, American Academy of Pediatrics

Board Certifications

American Board of Pediatrics - Pediatrics

Education & Training

Medical / Professional School(s)

1987, University of Damascus

Residency

1993, Pediatrics - MetroHealth Medical Center

Fellowship

1995, Neonatal-Perinatal Medicine - MetroHealth Medical Center

Expertise

Pediatric Emergency Medicine

Office Locations

UH Rainbow Babies and Children's Hospital
(216)844-8716
Department of Pediatrics-Emergency Medicine
11100 Euclid Ave
Cleveland, OH 44106
Get Directions

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

For calendar year 2012, Haitham Haddad, MD did not disclose any Outside Relationships with Industry.